Europe – Update : Draft ICH guideline Q3D (R2° on Elemental impurities – Step 2b

This document presents a process to assess and control elemental impurities in the drug product using the principles of risk management as described in ICH Q9. This process provides a platform for developing a risk-based control strategy to limit elemental impurities in the drug product…